Translate
Job title
Consultant histopathologist
Related services
Location
Biography
Dr Tran-Dang is a consultant histopathologist specialising in urological pathology.
She obtained her medical degree (with distinction) from Guy’s and St Thomas’ Medical School, London, and undertook specialist registrar histopathology training at Imperial College Healthcare NHS Trust hospitals, and the Royal Free Hospital.
Dr Tran-Dang is a member of the Academy of Medical Educators and is an educational supervisor for histopathology trainees.
GMC number
4763567
• J. Aquilina et al. “Epithelioid angiomyolipomas of the kidney: rare renal tumours associated with poor prognoses”. Urology 2023 (Oncology 176, p102-105). DOI: https://doi.org/10.1016/j.urology.2023.03.017
• Dawood et al. “Case report: Disease progression of renal cell carcinoma containing a novel putative pathogenic KAT6A:NRG1 fusion on Ipilimumab-Nivolumab immunotherapy. A case study and review of the literature.” Frontiers in Oncology 2023 13:1111706. DOI: 10.3389/fonc.2023.1111706
• J.B. Neves et al. “Defining the origin, evolution, and immune composition of SDH-deficient renal cell carcinoma.” iScience 2022, 25(11):105389. DOI: 10.1016/j.isci.2022.105389
• J.B. Neves et al. "Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma." World Journal of Urology 2021. https://doi.org/10.1007/s00345-021-03683-9
• P. Satish et al. “COVID intermediate prioritisation group is poorly predictive of pathological high risk among patients with renal tumours.” European Urology 2021 79: S850-S851. DOI: 10.1016/S0302-2838(21)00996-9
• J.B. Neves et al. “Growth and renal function dynamics of renal oncocytomas in patients on active surveillance." BJU International 2021. http://doi.org/10.1111/bju.15499
• T. Kuusk et al. "Impact of the first surge of the COVID-19 pandemic on a tertiary referral centre for kidney cancer." BJU International 2021. http://doi.org/10.1111/bju.15441
• J,B. Neves et al. “Renal tumour biopsy to reduce overtreatment of renal oncocytomas.” Journal of Clinical Oncology 2020 38(6_Supp): 623. DOI: 10.1200/JCO.2020.38.6_supp.623
• M. Tran et al. “First-in-human in vivo non-invasive assessment of intratumoral metabolic heterogeneity in renal cell carcinoma.” BJR Case Reports 2019; 5: 20190003